Clinical Trial Update: A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Phase 1/2 study evaluating combinations including HRS-2189 with other agents in advanced/metastatic breast cancer, currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fluvastatin (fluvastatin)
• HRS-1358 (HRS-1358)
• HRS-2189
• HRS-6209 (HRS-6209)
• HRS-8080

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Advanced Unresectable or Metastatic Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING